Polyplastics Adds POM to Medical-Grade Polymers Portfolio

A longtime supplier of cyclic olefin copolymers under the Topas brand to the medical technology sector, the Polyplastics Group has added Duracon polyoxymethylene/acetalis (POM) to its medical-grade polymers portfolio. The Duracon POM PM series is now commercially available globally for medical applications.

Polyplastics’ two acetal grades include standard viscosity PM09S01N, which delivers the reliable mechanical properties and moldability expected from POM, and PM27S01N, a high-flow grade that enables wall-thinning, miniaturization, and lightweighting of medical devices. 

Both grades meet medical device manufacturers’ key requirements and are targeted for a range of applications including drug contact and delivery. The materials are in compliance with ISO 10993 and USP Class VI for biocompatibility and cytotoxicity, have been submitted to FDA’s Drug Master File (DMF) and Device Master File (MAF), and comply with EU 10/2011 and FDA food contact 21 CFR 177.2470. The materials withstand hot steam and ethylene oxide (EtO) sterilization.  

The PM series adheres to strict quality management systems including conformity to the VDI 2017 medical-grade polymers standard. Full traceability of processes and products, and production management based on GMP principles are ensured.